Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 150 Results

Title
Intervention Indication Therapeutic Area Year Actions
Talimogene laherparepvec in addition to pembrolizumab for metastatic melanoma Pembrolizumab (Keytruda; MK-3475) , Talimogene laherparepvec (Imlygic; T-Vec) Melanoma Skin Cancer 2020 View  |  Download
Tafasitamab in combination with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma Tafasitamab (MOR208; Monjuvi) Diffuse large B-cell lymphoma (DLBCL) Haematological Cancer and Lymphomas 2020 View  |  Download
Semaglutide for overweight individuals ATB200/AT2221 , Semaglutide (Ozempic) Obesity , Weight management Endocrine Nutritional and Metabolic Disorders 2020 View  |  Download
Selinexor in addition to bortezomib and low-dose dexamethasone for relapsed or refractory multiple myeloma Bortezomib (Velcade; bortezomib mannitol boronic ester) , Dexamethasone (dexamethasone sodium metasulfobenzoate) , Selinexor (KPT-330; Xpovio) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2020 View  |  Download
Selinexor for advanced unresectable dedifferentiated liposarcoma Selinexor (KPT-330; Xpovio) Soft tissue sarcoma Sarcoma 2020 View  |  Download
Selinexor for advanced or recurrent endometrial cancer - maintenance therapy Selinexor (KPT-330; Xpovio) Endometrial cancer Female Reproductive Cancer 2020 View  |  Download
Rivoceranib for locally advanced or metastatic gastric or gastro-oesophageal junction cancer - after two or more therapies Rivoceranib (Apatinib; YN968D1) Gastric cancer , Gastro-oesophageal junction cancer Gastrointestinal Cancer 2020 View  |  Download
Ripretinib for treating advanced gastrointestinal stromal tumours – fourth-line Ripretinib (DCC-2618; Quinlock) Gastrointestinal stromal tumour (GIST) Gastrointestinal Cancer 2020 View  |  Download
Rigosertib for myelodysplastic syndrome - second line Rigosertib (Estybon; ON-01910.Na) Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2020 View  |  Download
Retifanlimab for squamous carcinoma of the anal canal – after platinum based chemotherapy Retifanlimab (INCMGA00012; MGA-012) Anal cancer Gastrointestinal Cancer 2020 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications